Quality of Life in Patients Undergone Vulvar Reconstruction After Vulvar Cancer Resection (3233)
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Nov 13, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the quality of life for women who have undergone surgery for vulvar cancer and subsequent reconstruction. The researchers want to understand how these surgeries affect patients before and after the procedures by using various questionnaires to gather information on different aspects of their lives, such as physical health, emotional well-being, and daily activities.
To be eligible for this trial, participants must be women who are scheduled for surgery to remove vulvar cancer and must agree to take part in the study. Unfortunately, individuals with certain conditions, like cognitive impairment or psychiatric disorders, cannot participate. Those who join the study can expect to answer questions about their health and well-being at different times to help researchers learn how such surgeries impact their quality of life. This information is important for improving care and support for future patients facing similar situations.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing surgery for vulvar cancer
- • Patients providing consent to be enrolled in the study
- Exclusion Criteria:
- • Cognitive impairment
- • psychiatric disorder
- • neurodegenerative disorder
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Trial Officials
Stefano Gentileschi, Prof.
Principal Investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported